0001062993-23-022120.txt : 20231207
0001062993-23-022120.hdr.sgml : 20231207
20231207195735
ACCESSION NUMBER: 0001062993-23-022120
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231206
FILED AS OF DATE: 20231207
DATE AS OF CHANGE: 20231207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Edward F
CENTRAL INDEX KEY: 0001368350
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39267
FILM NUMBER: 231473728
MAIL ADDRESS:
STREET 1: C/O POLYMEDIX, INC.
STREET 2: 3701 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Benitec Biopharma Inc.
CENTRAL INDEX KEY: 0001808898
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3940 TRUST WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: (510) 780-0819
MAIL ADDRESS:
STREET 1: 3940 TRUST WAY
CITY: HAYWARD
STATE: CA
ZIP: 94545
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-12-06
0001808898
Benitec Biopharma Inc.
BNTC
0001368350
Smith Edward F
C/O BENITEC BIOPHARMA INC.
3940 TRUST WAY
HAYWARD
CA
94545
1
0
0
0
0
Options (right to buy)
3.1301
2023-12-06
4
A
0
35000
0
A
2033-12-06
Common Stock
35000
35000
D
The stock options will vest in three substantially equal installments on the day prior to each of the Issuer's next three annual stockholder meetings occurring immediately following the date of grant.
/s/ Edward Smith
2023-12-07